Anesthesia Management for Pulmonary Cryoablation

Zvi C. Jacob, Stephanie Rashewsky, Ruth A. Reinsel, Thomas V. Bilfinger, William Moore

Department of Anesthesiology, Stony Brook University School of Medicine, New York, USA.
Department of Anesthesiology, Stony Brook University School of Medicine, New York, USA;.
Department of Radiology, Stony Brook University School of Medicine, New York, USA..
Department of Surgery, Stony Brook University School of Medicine, New York, USA.

DOI: 10.4236/ojanes.2013.34057                

Abstract

Lung tumors represent a major health impact globally. Pulmonary cryoablation treatment as a palliative measure for patients with non-operable pulmonary lesions has gained popularity over the last decade. With increasing case load and patients medical status becoming more complex, preparation for pulmonary cryoablation requires the implementation of an enhanced perioperative anesthetic plan. Current literature as well as our institutional experience shows that this patient population presents with multiple comorbidities raising the challenge of providing anesthetic care. These procedures are done under challenging conditions with limited resources and in remote locations in the hospital. A team approach by the anesthesiologist, thoracic surgeon, and interventional radiologist is critical to the success of this treatment. The present review examines our institution’s anesthetic management of percutaneous cryoablation treatment (PCT) in the treatment of non-operable lung cancer and metastases. The objective of this article is to review the current literature guidelines and to discuss our retrospective institutional experience in anesthesia management of PCT procedures.

Keywords

Anesthesia Care; Percutaneous Cryoablation Treatment; Lung Cancer; Pulmonary Complications; Pneumothorax; Hemoptysis

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	J. D. Minna, “Neoplasms of the Lung,” In: D. L. Dennis, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo and J. L. Jameson, Eds., Harrison’s Principles of Internal Medicine, McGraw-Hill Professional, Blacklick, 2005, pp. 506-515.
[2]	G. Asimakopoulos, J. Beeson, J. Evans and M. O. Maiwand, “Cryosurgery for Malignant Endobronchial Tumors,” Chest, Vol. 127, No. 6, 2005, pp. 2007-2014. doi:10.1378/chest.127.6.2007
[3]	M. O. Maiwand and G. Asimakopoulos, “Cryosurgery for Lung Cancer: Clinical Results and Technical Aspects,” Technology in Cancer Research and Treatment, Vol. 3, No. 2, 2004, pp. 143-150.
[4]	A. Zemlyak, W. H. Moore and T. V. Bilfinger, “Comparison of Survival after Sublobar Resections and Ablative Therapies for Stage I Non-Small Cell Lung Cancer,” Journal of the American College of Surgeons, Vol. 211, No. 1, 2010, pp. 68-72. doi:10.1016/j.jamcollsurg.2010.03.020
[5]	D. B. Goodie, M. D. Horton, R. W. Morris, L. S. Nagy and D. L. Morris, “Anaesthetic Experience with Cryotherapy for Treatment of Hepatic Malignancy,” Anaesthesia and Intensive Care, Vol. 20, No. 4, 1992, pp. 491-496.
[6]	K. Littlewood, “Anesthetic Considerations for Hepatic Cryotherapy,” Seminars in Surgical Oncology, Vol. 14, No. 2, 1998, pp. 116-121. doi:10.1002/(SICI)1098-2388(199803)14:2<116::AID-SSU4>3.0.CO;2-8
[7]	K. Miki, T. Shimomura, H. Yamada, K. Kishimoto, Y. Ohishi, J. Harada and S. Egawa, “Percutaneous Cryoablation of Renal Cell Carcinoma Guided by Horizontal Open Magnetic Resonance Imaging,” International Journal of Urology, Vol. 13, No. 7, 2006, pp. 880-884. |doi:10.1111/j.1442-2042.2006.01432.x
[8]	T. S. Ravikumar and G. D. Steele Jr., “Hepatic Cryosurgery,” Surgical Clinics of North America, Vol. 69, 1989, pp. 433-438.
[9]	G. J. Vricella, J. R. Haaga, B. L. Adler, D. Nakamoto, E. E. Cherullo, S. Flick and L. E. Ponsky, “Percutaneous Cryoablation of Renal Masses: Impact of Patient Selection and Treatment Parameters on Outcomes,” Urology, Vol. 77, No. 3, 2010, pp. 649-654. doi:10.1016/j.urology.2010.08.016
[10]	M. Moore, D. Kolnick, J. Tan and H. S. Yu, “CT Guided Percutaneous Cryoneurolysis for Post Thoracotomy Pain Syndrome,” Academic Radiology, Vol. 17, No. 5, 2010, pp. 603-606. doi:10.1016/j.acra.2010.01.009
[11]	H. Wang, P. J. Littrup, Y. Duan, Y. Zhang, H. Feng and Z. Nie, “Thoracic Mass Treated with Percutaneous Cryotherapy: Initial Experience with More than 200 Procedures,” Radiology, Vol. 235, No. 1, 2005, pp. 289-298. doi:10.1148/radiol.2351030747
[12]	N. E. Hoffman and J. C. Bischof, “The Cryobiology of Cryosurgical Injury,” Urology, Vol. 60, No. 2a, 2005, pp. 40-49. doi:10.1016/S0090-4295(02)01683-7
[13]	M. Kawamura, Y. Izumi, N. Tsukada, K. Asakura, H. Sugiura, H. Yashiro, K. Nakano, S. Nakatsuka, S. Kuribayashi and K. Kobayashi, “Percutaneous Cryoablation of Small Pulmonary Malignant Tumors under Computed Tomographic Guidance with Local Anesthesia for Nonsurgical Candidates,” Journal of Thoracic and Cardiovascular Surgery, Vol. 131, No. 5, 2006, pp. 1007-1013. doi:10.1016/j.jtcvs.2005.12.051